Antibacterial activity of synthesized 2,4,5-trisubstituted imidazole derivatives

Chemical Biology and Drug Design

Volumn 72, Issue 3, 2008, Pages 197-204

  Khan, Mohd Sajid ^a,c   Siddiqui, Shafi Ahmad ^a   Siddiqui, Mohammad Shaik Rafi Ahmad ^b   Goswami, Usha ^c   Srinivasan, Kumar Venkatraman ^a   Khan, Muhammad Islam ^a  

^a NATIONAL CHEMICAL LABORATORY   (India)

^b SCIENCE COLLEGE   (India)

^c NATIONAL INSTITUTE OF OCEANOGRAPHY   (India)

Author keywords

hydroxyketone; 1,2 Diketones; 2,4,5 Trisubstituted imidazoles; Antibacterial activity; Aryl aldehydes

Indexed keywords

2 (4,5 DIPHENYL 1H IMIDAZOL 2 YL)PHENOL; 2 FURAN 2 YL 4,5 DI 4 TOLYL 1H IMIDAZOLE; 4 (4,5 DIFURAN 2 YL 1H IMIDAZOL 2 YL) 2 METHOXYPHENOL; 4 (4,5 DIPHENYL 1H IMIDAZOL 2 YL)PHENOL; 4,5 DIFURAN 2 YL 2 (4 METHOXY PHENYL) 1H IMIDAZOLE; IMIDAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; DRUG ACTIVITY; DRUG DESIGN; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; GRAM-NEGATIVE BACTERIA; HUMANS; IMIDAZOLES; INHIBITORY CONCENTRATION 50; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PHENOLS;

FUNGI; KLEBSIELLA PNEUMONIAE; NEGIBACTERIA; POSIBACTERIA;

EID: 50449097740     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2008.00691.x     Document Type: Article

References (36)

1. Graczyk P.P., Khan A., Bhatia G.S., Palmer V., Medland D., Numata H. et al. (2005) The neuroprotective action of JNK3 inhibitors based on the 6, 7-dihydro-5H-pyrrolo [1, 2-a] imidazole scaffold. Bioorg Med Chem Lett 15:4666 4670.
2. Black J.W., Durant G.J., Emmett J.C., Ganellin R.C. (1974) Sulphur-methylene isosterism in the developent of metiamide, a new histamine H2-receptor antagonist. Nature 248:65 67.
3. Uaucu R., Karaburun N.G., Isikdag I. (2001) Synthesis and analgesic activity of some 1-benzyl-2-substituted-4, 5-diphenyl-1H-imidazole derivatives. Farmaco 56:285 290.
4. Mjalli A., Sarshar S., US 5700826 (1997) 19 pp.
5. Niwano Y., Koga H., Kodama H., Kanai K., Miyazaki T., Yamaguchi H. (1999) Inhibition of sterol 14 α-demethylation of Candida albicans with NND-502, a novel optically active imidazole antimycotic agent. Med Mycol 37:351 355.
6. Antolini M., Bozzoli A., Ghiron C., Kennedy G., Rossi T., Ursini A. (1999) Analogues of 4,5-bis(3,5-dichlorophenyl)-2-trifluoromethyl-1H-imidazole as potential antibacterial agents. Bioorg Med Chem Lett 9:1023 1028.
7. Liberatore A., Schulz J., Pommier J., Barthelemy M., Huchet M., Chabrier P. et al. (2004) 2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators. Bioorg Med Chem Lett 14:3521 3523.
8. Odds F.C. (1988) Candida and Candidosis, 2nd edn. London:Bailliere Tindall.
9. Simonetti N., D'Auria F.D., Strippoli V. (1993) Short term contact activity of miconazole sulfosalicylate and econazole sulfosalicylate. Eur Bull Drug Res 2:123 128.
10. Duquenoy P., Ruysschaert J.M. (1993) Interaction between lipids and miconazole sulfosalicylate and econazole sulfosalicylate. Eur Bull Drug Res 2:129 134.
11. Aoyama Y., Yoshida Y., Sato R. (1984) Yeast cytochrome P-450 catalyzing lanosterol 14 α-demethylation. II. Lanosterol metabolism by purified P-450(14) DM and by intact microsomes. J Biol Chem 259:1661 1666.
12. Laignelet L., Narbonne J.F., Lhuguenot J.C., Riviere J.L. (1989) Induction and inhibition of rat liver cytochrome(s) P-450 by an imidazole fungicide (prochloraz). Toxicology 59:271 284.
13. Vinggaard A.M., Hass U., Dalgaard M., Andersen H.R., Jørgensen E.V., Christiansen S., Laier P., Poulsen M.E. (2006) Prochloraz: an imidazole fungicide with multiple mechanisms of action. Int J Androl 29:186 192.
14. Godefroi E.F., Heeres J., Van Cutsem J., Janssen P. (1969) Preparation and antimycotic properties of derivatives of 1-phenethylimidazole. J Med Chem 12:784 791.
15. Bastide M., Jouvert J., Bastide J.M. (1982) A comparison of the effects of several santifungal imidazole derivatives and polyenes on Candida albicans: an ultrastructural study by scanning electron microscopy. Can J Microbiol 28:1119 1126.
16. Henry H., Sisler H.D. (1979) Effects of miconazole and dodecylimidazole on sterol biosynthesis in Ustilago maydis. Antimicrob Agents Chemother 11:158 166.
17. Saeki T., Umezawa H., Fujishige T.T., Hori M. (1974) Biological effect of azomycin (2-nitro imidazole): inhibition of ribonucleotide reductase. J Antibiot 27:225 227.
18. Iwata K., Yamaguchi H. (1973) Mechanism of action of clotrimazole. 1. Survey of the principal action on Candida albicans cells. Jpn J Bacteriol 28:513 521.
19. Van den Bossche H., Willemsens G., Cools W., Lauwers W.F., Le Jeune L. (1978) Biochemical effects of miconazole on fungi. II. Inhibition of ergosterol biosynthesis in Candida albicans. Chem Biol Interact 21:59 78.
20. Hoffer M., Grunberg E. (1974) Synthesis and antiprotozoal activity of 1-(3-chloro-2-hydroxypropyl)-substituted nitroimidazoles. J Med Chem 17:1019 1020.
21. Wasserscheid P., Welton T. ed. (2003) Efficient Synthesis of Arylsulfamides by Reaction of Amines with Arylsulfamoyl Imidazolium Triflate Ionic Liquids in Synthesis. Weinheim:Wiley VCH.
22. Siddiqui S.A., Narkhede U.C., Palimkar S.S., Daniel T., Lahoti R.J., Srinivasan K.V. (2005) Room temperature ionic liquid promoted improved and rapid synthesis of 2,4,5-triaryl imidazoles from aryl aldehydes and 1,2-diketones or α-hydroxyketone. Tetrahedron 61:3539 3546.
23. Baur A.W., Kirby W.M.M., Sherris J.C., Turch M. (1966) Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 45:493 496.
24. Amsterdam D. (1991) Susceptibility testing of antimicrobials in liquid media. In:Lorian V., editor. Antibiotics in Laboratory Medicine. Baltimore:Williams &Wilkins p. 72 78.
25. Stenger S., Hanson D.A., Teitelbaum R. (1998) An antimicrobial activity of cytolytic T cells mediated by granulysin. Science 282:121 125.
26. Hamamoto K., Kida Y., Zhang Y., Shimizu T., Kuwano K. (2002) Antimicrobial activity and stability to proteolysis of small linear cationic peptides with d-amino acid substitutions. Microbiol Immunol 46:741 749.
27. Acros M., Arcos J.C. (1958) A correlation of constitution and carcinogenic activity. I. A study of the essential molecular parameters. Arzneimittelforschung 8:486 488.
28. Miwa G.T., West S.B., Walsh J.S., Wolf F.J., Lu A.Y.H. (1982) Drug residue formation from ronidazole, a 5-nitroimidazole. III. Studies on the mechanism of protein alkylation in vitro. Chem Biol Interact 41:297 312.
29. Chang L.L., Sidler K.L., Cascieri M.A., de Laszlo S., Koch G., Li B., et al. (2001) Substituted imidazoles as glucagon receptor antagonists. Bioorg Med Chem Lett 11:2549 2553.
30. Laufer S.A., Wagner G.K., Kotschenreuther D.A., Albrecht W. (2003) Novel substituted pyridinyl imidazoles as potent anticytokine agents with low activity against hepatic cytochrome P450 enzymes. J Med Chem 46:3230 3244.
31. Gallagher T.F., Fier-Thompson S.M., Garigipati R.S., Sorenson M.E., Smietana J.M., Lee D., et al. (1995) 2,4,5-Triarylimidazole inhibitors of IL-1 biosynthesis. Bioorg Med Chem Lett 5:1171 1176.
32. Lee J.C., Badger A.M., Griswold D.E., Dunnington D., Truneh A., Votta B., et al. (1993) Bicyclic imidazoles as a novel class of cytokine biosynthesis inhibitors. Ann N Y Acad Sci 30 696:149 70.
33. Waitz J.A., Moss E.L., Weinstein M.J. (1971) Chemotherapeutic evaluation of clotrimazole [Bay b 5097, 1 (o-chloro-α-α-diphenylbenzyl) imidazole]. Appl Microbiol 22:891 898.
34. Lipinski C.A. (1995) Computational alerts for potential absorption problems: profiles of clinically tested drugs. In:Tools for Oral Absorption. Part Two. Predicting Human Absorption. BIOTEC, PDD symposium. Miami:AAPS.
35. Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 23:3 25.
36. Bendesky A., Menéndez D., Wegman P.O. (2002) Is metronidazole carcinogenic? Mutat Res 511:133 144.